Distribution Intelligence Systems v. Stryker: Knotless Anchor Patent Suit Dismissed
Distribution Intelligence Systems, LLC filed suit against Stryker Corporation in the Eastern District of Texas, asserting US8617160B2 against the REELX STT Knotless Anchor System. The case closed just 44 days after filing when the plaintiff voluntarily dismissed without prejudice — leaving the door open for future action.
A 44-day patent skirmish over orthopedic anchor IP ends quietly
Distribution Intelligence Systems, LLC filed Case No. 2:24-cv-00334 in the Eastern District of Texas on 7 May 2024, asserting US Patent No. 8,617,160 B2 against Stryker Corporation’s REELX STT Knotless Anchor System. Stryker, a global medical device major, was represented by Gregory S. Gewirtz of Lerner David LLP, while plaintiff was represented by Randall T. Garteiser of Garteiser Honea PLLC — a firm known for patent assertion activity in E.D. Tex.
The case closed on 20 June 2024 — just 44 days after filing — when Distribution Intelligence Systems filed a Notice of Dismissal under Rule 41(a)(1)(A)(i). The court accepted and acknowledged the notice, dismissing all claims without prejudice and denying all remaining relief requests as moot. A dismissal without prejudice means the plaintiff retains the right to re-file the same claims against Stryker in a future proceeding, subject to any applicable statutes of limitations.
The 44-day duration is notably short even by the standards of early dismissals and suggests the matter resolved — or was reconsidered — before any substantive litigation activity such as an answer, motion to dismiss, or Markman briefing. Whether the parties reached a private arrangement or the plaintiff simply reassessed its litigation position is not disclosed in the public record. The without-prejudice designation keeps strategic optionality alive, which may itself be commercially significant for a patent assertion entity operating in the orthopedic device space.
Filing to Voluntary dismissal in 44 days
44 days — well below the median E.D. Tex. patent case duration, suggesting early exit strategy
Voluntarily dismissed: what the without-prejudice ruling means for both parties
Rule 41(a)(1)(A)(i): plaintiff’s unilateral exit before answer
Under Rule 41(a)(1)(A)(i), a plaintiff may voluntarily dismiss a case without a court order by filing a notice before the defendant serves an answer or a motion for summary judgment. This is the most procedurally clean exit available — it requires no consent from the defendant and carries no judicial merits ruling. The court here accepted and acknowledged the notice, confirming the dismissal was procedurally proper.
No merits adjudicatedThe distinction between with and without prejudice matters greatly
A dismissal without prejudice does not extinguish the underlying claims — the plaintiff can re-file the same infringement allegations against Stryker in a future action. A dismissal with prejudice, by contrast, would bar any future claim on the same patent against the same defendant. The public record here is explicit: the Notice stated ‘WITHOUT PREJUDICE’ and the court’s order confirmed this. No settlement or licensing term appears in the docket.
Re-filing remains possibleStryker exits without an invalidity or non-infringement ruling
Stryker obtains a clean exit from this proceeding without any adverse judgment, but gains no formal legal protection against a future assertion of US8617160B2. Because no answer was served before dismissal, Stryker had no opportunity to establish invalidity or non-infringement on the record. This leaves the patent’s enforceability against the REELX STT Knotless Anchor System an open question — and Stryker potentially exposed to a re-filed suit.
No declaratory judgment obtainedPatent threat to Stryker’s knotless anchor line remains live
For competitors and supply chain participants in the orthopedic knotless anchor space, this outcome suggests US8617160B2 remains an active assertion risk. Distribution Intelligence Systems’ decision to dismiss without prejudice — rather than seeking a settlement with prejudice — typically signals either ongoing negotiations or a preserved enforcement strategy. Companies designing or distributing knotless anchor systems should monitor this patent and any continuation applications.
Enforcement risk preservedFull party and counsel information
| Role | Name | Type | Detail |
|---|---|---|---|
| Plaintiff | Distribution Intelligence Systems, LLC | Company | Patent assertion entity — holder of US8617160B2 covering knotless anchor technologySearch in Eureka ↗ |
| Defendant | Stryker Corporation | Company | Stryker Corporation — global medical device manufacturer, orthopedic surgical productsSearch in Eureka ↗ |
| Plaintiff counsel | Randall T. Garteiser | Attorney | Counsel for Distribution Intelligence Systems, LLCSearch in Eureka ↗ |
| Plaintiff law firm | Garteiser Honea PLLC | Law Firm | Representing Distribution Intelligence Systems, LLCSearch in Eureka ↗ |
| Defendant counsel | Gregory S. Gewirtz | Attorney | Counsel for Stryker CorporationSearch in Eureka ↗ |
| Defendant law firm | Lerner David LLP | Law Firm | Representing Stryker CorporationSearch in Eureka ↗ |
| Presiding judge | Judge N/A | Judge | Texas Eastern District CourtSearch in Eureka ↗ |
Official order — verbatim text
The court’s order is procedural rather than substantive — it accepts the plaintiff’s Rule 41(a)(1)(A)(i) notice and confirms dismissal without prejudice, denying all remaining relief as moot. Critically, the order contains no claim construction, no validity ruling, and no infringement finding. The explicit ‘WITHOUT PREJUDICE’ language, reproduced verbatim from the plaintiff’s notice, is the operative term: it preserves Distribution Intelligence Systems’ right to re-assert these claims, and forecloses any res judicata defence by Stryker in a future action on the same patent.
US8617160B2 — Orthopedic knotless anchor surgical fixation technology
US8617160B2, filed under application number US13/043173, covers technology in the orthopedic surgical anchor domain — specifically knotless anchor systems used in soft-tissue fixation procedures. Knotless anchors are widely used in shoulder, knee, and hip arthroscopic surgery to reattach tendons and ligaments to bone without the complexity of traditional knot-tying techniques. The ‘B2’ designation indicates the patent issued with an examination amendment, suggesting the claims were refined during prosecution.
The REELX STT Knotless Anchor System — the accused product — is a component of Stryker’s arthroscopic surgery portfolio, a high-value segment of the global orthopedic device market. Assertion of this patent against a product of this commercial significance by a non-practising entity suggests Distribution Intelligence Systems views the claims as broadly applicable to current market-leading knotless anchor architectures. Other manufacturers competing in the knotless anchor space — including those producing all-suture, PEEK, and titanium anchor variants — should assess whether their designs fall within the claim scope.
Should your knotless anchor product be cleared against US8617160B2?
Any company designing, manufacturing, or distributing knotless suture anchor systems for orthopedic surgery should treat US8617160B2 as a live clearance risk. The patent has now been asserted against Stryker’s flagship REELX STT system and remains in force with no invalidity finding on record. R&D teams developing next-generation anchor systems — particularly those incorporating similar fixation or tensioning mechanisms — face meaningful infringement exposure if clearance is not confirmed.
PatSnap Eureka’s FTO Search Agent can rapidly analyse the full claim set of US8617160B2, map the complete patent family including any continuations or divisionals, and identify prior art that could support an invalidity challenge if needed. Eureka also surfaces forward citations to flag whether similar claims have been asserted in parallel litigation — giving your legal and product teams the complete picture before launch or acquisition.
Run a freedom-to-operate analysis on US8617160B2 to assess your product’s exposure
Run FTO in Eureka →Similar orthopedic device patent cases in E.D. Texas
Explore patent infringement cases involving orthopedic surgical anchors and fixation technology filed in the Eastern District of Texas with comparable dismissal or assertion patterns.
What this case signals for the orthopedic device IP landscape
A 44-day voluntary dismissal without prejudice in E.D. Tex. rarely signals the end of a patent assertion strategy.
E.D. Tex. remains a preferred venue for medical device patent assertion
The Eastern District of Texas continues to attract patent infringement filings in the orthopedic and surgical device sector. Filing and quickly withdrawing without prejudice is consistent with a strategy to pressure defendants, test responsive counsel, or create negotiating leverage before re-engagement. Companies with product lines in this space should maintain active docket monitoring.
Without-prejudice exit preserves the plaintiff’s full enforcement arsenal
Distribution Intelligence Systems retains the right to re-assert US8617160B2 against Stryker — or any other knotless anchor manufacturer. The absence of any disclosed settlement or licensing agreement means the patent threat is not neutralised. In-house counsel at orthopedic device companies should treat this as a watch-list patent, not a resolved matter.
Distribution v Stryker — key questions answered
The voluntary dismissal without prejudice means all infringement claims regarding US8617160B2 were dropped before any merits ruling. Critically, Distribution Intelligence Systems retains the right to re-file the same claims against Stryker in a future action. No settlement, licensing deal, or invalidity finding was disclosed in the public docket.
No. The case was dismissed before any substantive litigation activity — no answer was filed, no claim construction occurred, and no validity ruling was issued. US8617160B2 remains in force with its enforceability against the REELX STT Knotless Anchor System unresolved.
The Eastern District of Texas is a historically plaintiff-favourable venue for patent infringement cases, with established local patent rules and experienced patent judges. Garteiser Honea PLLC, plaintiff’s counsel, regularly files patent cases in E.D. Tex., consistent with a systematic patent assertion approach in that jurisdiction.
The REELX STT Knotless Anchor System is a Stryker orthopedic product used in arthroscopic soft-tissue fixation procedures. It was identified as the accused product in the infringement action based on US8617160B2. The specific claims alleged to be infringed were not publicly disclosed before the case was dismissed.
Yes. A dismissal without prejudice under Rule 41(a)(1)(A)(i) does not preclude re-filing. Distribution Intelligence Systems may re-assert US8617160B2 against Stryker provided the applicable statute of limitations has not expired and the patent remains in force. This makes the outcome materially different from a dismissal with prejudice or a consent judgment.
PatSnap Eureka searches patents and litigation data to answer instantly.